Advancing Education on Biosimilars Act of 2020

Summary

Advancing Education on Biosimilars Act of 2019 This bill addresses education for the public and for health care providers regarding biosimilars. (Biosimilars are biological products approved by the Food and Drug Administration based on their similarity to an already approved biological product.) The bill requires the Department of Health and Human Services (HHS) to create a website for educational materials on the meaning and use of biosimilars and interchangeable biological products. HHS must also develop or improve continuing medical education programs for health care providers regarding biosimilars.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

6 official files

• Engrossed in Senate (text)

  Engrossed in Senate · EN · 17 December 2020

  ViewDownloadOpen at official source

• Engrossed in Senate (PDF)

  Engrossed in Senate · EN · 17 December 2020

  ViewDownloadOpen at official source

• Passed Senate

  summary · EN · 17 December 2020

  Open at official source

• Introduced in Senate (text)

  Introduced in Senate · EN · 23 May 2019

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 23 May 2019

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 23 May 2019

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.